RxDoctor Payments Data

Bernard Kulper

Hematology & Oncology · Avenel, NJNPI 1063499218

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,499 of the $6,820 with a category attached, or 66.0%. 21 manufacturers reported payments, led by Astellas Pharma US Inc at 29.5% of the total. Reporting peaked in 2022 at $2,302 and has fallen 71.8% since, to $650 in 2025.

$6,820in general payments, 2019–2025

Across 70 payments — averaging $97.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$2K
  • Taiho Oncology, Inc.$1K
  • Daiichi Sankyo Inc.$941
  • Incyte Corporation$659
  • AstraZeneca$525
  • E.r. Squibb & Sons, L.L.C.$377
  • plus $907 from 15 others

What the payments were for

  • Consulting fees$4,49966%
  • Speaking & faculty fees$3004%
  • Food & beverage$1,95229%
  • Education$701%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,820 in reported general payments places this provider in the 65th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey →

Other hematology & oncology in Avenel

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →